Company intelligence / Profile preview

Acme Progen Biotech

Salem, Tamil Nadu, Indiaprogenbiotech.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Acme Progen Biotech develops rapid diagnostic kits for early detection of human and animal diseases, provides molecular diagnosis, analytical lab testing, DNA sequencing/barcoding/gene expression analysis, manufactures scientific instruments for life science research. Their molecular biology lab is NABL-accredited and ICMR-approved for COVID-19 testing. The company has been active in supporting pandemic response with approved diagnostics.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic kit (for human and animal diseases)Molecular diagnostic servicesAnalytical laboratory testing services
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Acme Progen Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acme Progen Biotech.

Explore the full profile